Fibrotic NASH Index (FNI)
ورودیهای بالینی بیمار
حداقل ۵ — حداکثر ۱۰۰۰ • واحد: U/L
حداقل ۳ — حداکثر ۲۰ • واحد: %
حداقل ۱۰ — حداکثر ۲۰۰ • واحد: mg/dL
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low Risk0–0.1
- Indeterminate Risk0.1–0.33
- High Risk0.33–1
The Fibrotic NASH Index (FNI) calculates assessing gastrointestinal disease severity, endoscopic intervention urgency, and rebleeding risk. Key inputs include ast. Scores guide timing emergent endoscopy, initiating high-dose proton pump inhibitor infusions, or obtaining surgical consultation. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Screens for fibrotic NASH in individuals at high risk for NAFLD. Uses AST, HbA1c, and HDL cholesterol to calculate probability of fibrotic nonalcoholic steatohepatitis.
Clinical Indication
The Fibrotic NASH Index (FNI) is indicated for bedside clinical practice to support Screens for fibrotic NASH in individuals at high risk for NAFLD. Uses AST, HbA1c, and HDL cholesterol to calculate probability of fibrotic nonalcoholic steatohepatitis.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with upper or lower gastrointestinal hemorrhage, acute pancreatitis, acute liver failure, or inflammatory bowel disease. Clinical application is indicated across Endoscopy suites, emergency GI triage, acute medical floors, and hepatology services.
Limitations & Contraindications
Initial hemoglobin values in hyperacute hemorrhage may falsely appear normal prior to complete extravascular-to-intravascular fluid equilibration.
Clinical Pearls & Action Plan
Aggressive intravascular volume resuscitation and blood product support must precede diagnostic or therapeutic endoscopy.
FNI = e^x / (1 + e^x), where x = -10.33 + 2.54 × ln(AST) + 3.86 × ln(HbA1c) - 1.66 × ln(HDL)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| ast | float | Yes | Aspartate aminotransferase (AST) level(U/L) |
| hba1c | float | Yes | Hemoglobin A1c (glycated hemoglobin)(%) |
| hdl | float | Yes | HDL cholesterol level(mg/dL) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–0.1 | Low Risk | Fibrotic NASH ruled out |
| 0.1–0.33 | Indeterminate Risk | Further evaluation needed |
| 0.33–1 | High Risk | Likely fibrotic NASH |
Evidence-Based References (EBM)
- Tavaglione F, Jamialahmadi O, De Vincentis A, Qadri S, Mowlaei ME, Mancina RM, et al. Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis. Clin Gastroenterol Hepatol. 2023 Jun;21(6):1523-1532.e1. doi: 10.1016/j.cgh.2022.03.044.DOI: 10.1016/j.cgh.2022.03.044